World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 October 2017
Main ID:  NCT01097863
Date of registration: 31/03/2010
Prospective Registration: No
Primary sponsor: CIBA VISION
Public title: Clinical Validation of the New Print on Focus DAILIES Toric
Scientific title:
Date of first enrolment: March 2010
Target sample size: 280
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01097863
Study type:  Interventional
Study design:   
Phase:  N/A
Countries of recruitment
United States
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Be of legal age and sign written Informed Consent Document. If under legal age, parent
or guardian must sign Informed Consent Document and subjects ages 12 through 17 must
sign Informed Assent.

- Willing and able to wear study lenses in both eyes in the available parameters.

- Light-eyed subjects.

- Able to achieve 20/40 or better distance visual acuity (VA) in each eye at time of
dispensing.

- Optimal or acceptable fit in each eye at time of dispensing.

- Willing to wear the study lenses at least 8 hours a day, 5 days a week.

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Eye injury or surgery within twelve weeks prior to enrollment for this trial.

- Pre-existing ocular irritation that would preclude contact lens fitting.

- Currently enrolled in an ophthalmic clinical trial.

- Evidence of systemic or ocular abnormality, infection or disease which is likely to
affect successful wear of contact lenses or use of their accessory solutions as
determined by the investigator.

- Any use of medications for which contact lens wear could be contraindicated as
determined by the investigator.

- RGP contact lens wearer.

- Other protocol-defined exclusion criteria may apply.



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Myopia
Intervention(s)
Device: nelfilcon A contact lens, no inversion indicator
Device: nelfilcon A contact lens, inversion indicator
Device: nelfilcon A contact lens, modified inversion indicator
Primary Outcome(s)
Visibility of the Inversion Indicator on Lens When Lens Was on Participant's Finger, for Example, During Lens Insertion. [Time Frame: 1 week]
Secondary Outcome(s)
Secondary ID(s)
P-346-C-010
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 27/06/2011
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT01097863
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history